Skip to content

Prospective Observational Study: Optimization treatment of osteonecrosis of the femoral head based on China-Japan Friendship Hospital classification system

Prospective Observational Study: Optimization treatment of osteonecrosis of the femoral head based on China-Japan Friendship Hospital classification system

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17012984
Enrollment
Unknown
Registered
2017-10-15
Start date
2017-10-13
Completion date
Unknown
Last updated
2017-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteonecrosis of the femoral head

Interventions

impacted graft:impacted graft
arthroplasty:arthroplasty

Sponsors

Centre for Osteonecrosis and Joint-preserving & Reconstruction, Orthopaedic Department, China-Japan Friendship Hospital.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Osteonecrosis of femoral head; 2. Patient with any age; 3. Receive treatment, cooperate with the follow-up; 4. Voluntarily signed informed consent.

Exclusion criteria

Exclusion criteria: 1. End stage osteonecrosis of femoral head, receiving other treatment; 2. The younger, older patients, patients with pregnancy or lactation; 3. Superficial or deep infection of hip, osseous metastasis; 4. Severe hypertension and unstable blood pressure, serious arrhythmia, patients with cardiac pacemaker implantation; 5. Clotting disorders, or thrombosis; 6. Obesity (BMI>35); 7. Other clinical subjects; 8. With poor compliance; 9. Other unfavorable reason.

Design outcomes

Primary

MeasureTime frame
Harris score;VAS score;imaging evaluation;

Countries

China

Contacts

Public ContactWei Sun

Centre for Osteonecrosis and Joint-preserving & Reconstruction, Orthopaedic Department, China-Japan Friendship Hospital, Beijing

sun887@163.com+86 13910259975

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026